Patients with polymedication
Conditions
Interventions
Group 1: Depending on the analysis:
Patients cared for by physicians or pharmacists involved in the ARMIN project (retrospective analysis of claims data)
Patients enrolled in the medication management
Sponsors
Abteilung Klinische Pharmakologie und Pharmakoepidemiologie, Medizinische Klinik
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: CLAIMS DATA ANALYSIS: Patients (AOK PLUS responsible, sample size refers to the claims data analysis only): -Insured member of AOK PLUS, -no permanent inpatient care in nursing facilities, -enrollment in medication management (module 3) incl. selection of a physician participating in ARMIN and a pharmacy participating in ARMIN, -concurrent drug therapy with at least 5 active substances for systemic use in permanent medication (period of at least 6 months). QUESTIONNAIRES (UKHD responsible): Physicians and pharmacists: -Enrollment in medication management (module 3), -at least 1 patient managed in medication management (medication list status 7). Max. sample size according to inclusion criteria: Physicians: 165, Pharmacists: 243, Patients: 4757. Interviews (UKHD responsible): Physicians and pharmacists: - Non-participation in ARMIN Sample size: physicians: 35, pharmacists: 15
Exclusion criteria
Exclusion criteria: Withdrawal of informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Claims data analysis (including interrupted-time-series): -Hospitalization, -mortality, -inappropriate healthcare, -adherence, -drug interactions. Questionnaires: -Implementation and feasibility of modules, -Collaboration of health professionals, -Satisfaction of health professionals and patients with the ARMIN program. Interviews: -reasons for not participating. | — |
Secondary
| Measure | Time frame |
|---|---|
| Economic effects: -Drug costs, -personnel costs, -material costs. | — |
Countries
Germany
Contacts
Public ContactAndreas Fuchs
AOK PLUS
Outcome results
None listed